General Information
Revision date
2003-07-22
Product name
C9359A - No 59 Photo
Icons in SDS
Company Information
company name
Hewlett-Packard Company
Section 2
EU Classification
Weight 2-Pyrrolidone 616-45-5 210-843-1 Xi; R36/37/38 1,5-Pentanediol 111-29-5 203-854-4 not classified Ethyl alkyldiol confidential <14 not classified Alkyldiol ethoxylate confidential Xn; R21/22-38-41 Water 7732-18-5 231-791-2 >50 not classified For medium grey ink formulation Component/Substance CAS Number EU Number % by Weight 2-Pyrrolidone 616-45-5 210-843-1 Xi; R36/37/38 1,5-Pentanediol 111-29-5 203-854-4 not classified Ethyl alkyldiol confidential <14 not classified Alkyldiol ethoxylate confidential Xn; R21/22-38-41 Water 7732-18-5 231-791-2 > 50 not classified For light grey ink formulation Component/Substance CAS Number EU Number % by Weight 2-Pyrrolidone 616-45-5 210-843-1 Xi; R36/37/38 1,5-Pentanediol 111-29-5 203-854-4 not classified Ethyl alkyldiol confidential <14 not classified Alkyldiol ethoxylate confidential Xn; R21/22-38-41 Water 7732-18-5 231-791-2 > 50 not classified 3.0 Hazard Identification The black, medium grey, and light grey inks are not classified according to EU Directive 1999/45/EC. Routes of Exposure: Potential routes of overexposure to this product are skin and eye contact. Inhalation of vapor and ingestion are not expected to be significant routes of exposure for this product under normal use conditions. Complete toxicity data are not available for this specific formulation. Acute Health Hazards: Any potential hazards are presumed to be due to exposure to the components. 2-Pyrrolidone: Contact with eyes and skin may result in irritation. Inhalation may result in respiratory irritation. Ingestion may result in nausea, vomiting, and diarrhea. 1,5-Pentanediol: Contact with eyes and skin may cause irritation. Ethyl alkyldiol: Contact with eyes and skin may cause mild irritation. Alkyldiol ethoxylate: Contact with eyes may result in severe irritation and corneal injury. Contact with skin may result in severe irritation. Ingestion may cause irritation of mouth, throat, nausea, vomiting and diarrhea. Chronic Health Hazards: None known Carcinogenicity: None of the components present in this formulation at concentrations equal to or greater than 0.1% are listed by EU, MAK, IARC, NTP or OSHA.